Neuroendocrine neoplasm
Clinical trials for Neuroendocrine neoplasm explained in plain language.
Never miss a new study
Get alerted when new Neuroendocrine neoplasm trials appear
Sign up with your email to follow new studies for Neuroendocrine neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink Hard-to-Treat neuroendocrine liver tumors
Disease control CompletedThis phase 2 pilot study tests whether combining the immunotherapy drug pembrolizumab (Keytruda) with liver-directed treatments (like embolization or radiation) or peptide receptor radionuclide therapy (PRRT) can shrink tumors in people with well-differentiated neuroendocrine tum…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase 2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Immunotherapy-Radiation combo shows promise in tough lung cancer
Disease control CompletedThis early-phase trial tested the safety and best dose of the immunotherapy drug pembrolizumab when combined with chemotherapy and radiation for people with small cell lung cancer. The goal was to see if adding pembrolizumab helps the immune system fight the cancer more effective…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC